NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/31/2022
Back to search
Official data from USPTO
SEPTICYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEPTICYTE
ST13
US500000088777788Class
1, 5, 10, 44
Filing
88777788
Registration
6741924
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/21/2023
Trademark type
Word
Nice classes
1, 5, 10, 44
Filing date
01/29/2020
Registration date
05/31/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2022
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Boonah, Queensland, AU
Examiner
SOBRAL, CHRISTINA
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ImmuneXpress Pty Ltd
Representatives
Leigh Ann Lindquist SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological chemical test kits for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disordersfor diagnosis and treatment of sepsis
Class 5
Clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Class 10
Surgical and medical apparatus and instruments for use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders; peripheral blood or immune cell diagnostic test apparatus for analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders; diagnostic testing kits in this class consisting primarily of probesbuffers and reagents for use in microbial testing; point of care medical devicesdevices using nucleic acid amplification in the nature of real-time polymerase chain reaction or isothermal amplificationDNA sequencing or analyte quantification in the nature of mass spectrometryprotein array for analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Class 44
Medical services; medical pathology services; medical pathology services being the analysis of body fluid samples; medical services being molecular diagnostic services and taking of body fluid samples of others; providing informationadvisory and consultancy services in relation to medical servicesmedical pathology servicesthe analysis of body fluid samplesmedical services being molecular diagnostic services and taking of body fluid samples of others
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2022
PUBO
PUBLISHED FOR OPPOSITION
03/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/23/2022
OTHE
CASE RETURNED TO EXAMINATION
02/08/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/08/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
02/07/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
02/07/2022
APET
ASSIGNED TO PETITION STAFF
02/03/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
01/21/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2021
EX2G
SOU EXTENSION 2 GRANTED
12/08/2021
EXT2
SOU EXTENSION 2 FILED
12/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/10/2021
EX1G
SOU EXTENSION 1 GRANTED
06/08/2021
EXT1
SOU EXTENSION 1 FILED
06/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/08/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2020
PUBO
PUBLISHED FOR OPPOSITION
10/13/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/17/2020
GNRT
NON-FINAL ACTION E-MAILED
04/17/2020
CNRT
NON-FINAL ACTION WRITTEN
04/17/2020
DOCK
ASSIGNED TO EXAMINER
04/17/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/12/2020
ALIE
ASSIGNED TO LIE
02/12/2020
ALIE
ASSIGNED TO LIE
02/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/04/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/03/2020
NWAP
NEW APPLICATION ENTERED
02/01/2020
Continuous trademark protection
Get notified about every new filing that threatens SEPTICYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.